|Bid||2.8600 x 1400|
|Ask||2.8700 x 1400|
|Day's range||2.8300 - 2.9500|
|52-week range||2.7700 - 7.7500|
|Beta (5Y monthly)||1.38|
|PE ratio (TTM)||N/A|
|Earnings date||05 May 2021 - 10 May 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||13.60|
Chiasma, Inc. ( NASDAQ:CHMA ) shareholders might be concerned after seeing the share price drop 27% in the last...
Except as required by law, Chiasma disclaims any obligation to update information contained in these forward-looking statements, whether as a result of new information, future events or otherwise. Joining the call today is Raj Kannan, chief executive officer; Anand Varadan, executive vice president and chief commercial officer; Bill Ludlam, senior vice president of Clinical Development and Medical Affairs; and John Doyle, senior vice president and chief financial officer.
Chiasma (CHMA) delivered earnings and revenue surprises of 8.57% and -17.75%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?